Ortho V. Mylan: Key Ruling For 2 Statutory Provisions

Law360 (July 18, 2008, 12:00 AM EDT) -- On March 31, 2008, the Court of Appeals for the Federal Circuit ("CAFC") issued its opinion in Ortho-McNeil Pharmaceutical Inc. v. Mylan Laboratories Inc., 520 F.3d 1358 (Fed. Cir. 2008) ("Ortho v. Mylan"), a case concerning Ortho-McNeil's blockbuster epilepsy and migraine drug, Topamax (generic name, topiramate)....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!